These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 12333)

  • 1. "First pass effect" after rectal administration of thiazinamium methylsulphate [proceedings].
    Jonkman JH; van Bork LE; Wijsbeek J; de Zeeuw RA; Orie NG; Cox HL
    J Pharm Pharmacol; 1976 Dec; 28 Suppl():56P. PubMed ID: 12333
    [No Abstract]   [Full Text] [Related]  

  • 2. Proceedings: Bioavailability of the quaternary ammonium compound thiazinamium methylsulphate (Multergan) after oral and intramuscular administration.
    Jonkman JH; Wijsbeek U; Brouwer SH; De Zeeuw RA
    J Pharm Pharmacol; 1974 Dec; 26 Suppl():63P. PubMed ID: 4156742
    [No Abstract]   [Full Text] [Related]  

  • 3. First-pass effect after rectal administration of thiazinamium methylsulfate.
    Jonkman JH; van Bork LE; Wijsbeek J; Bolhuis-de Vries AS; de Zeeuw RA; Orie NG; Cox HL
    J Pharm Sci; 1979 Jan; 68(1):69-72. PubMed ID: 758468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism and excretion of the quaternary ammonium compound thiazinamium methylsulfate (Multergan) in man. II. Oral and rectal administration.
    Jonkman JH; Wijsbeek J; De Zeeuw RA; Van Bork LE; Orie NG
    Pharm Weekbl Sci; 1982 Oct; 4(5):129-34. PubMed ID: 6128714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the bioavailability of oral, rectal and intramuscular promethazine.
    Schwinghammer TL; Juhl RP; Dittert LW; Melethil SK; Kroboth FJ; Chung VS
    Biopharm Drug Dispos; 1984; 5(2):185-94. PubMed ID: 6743785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variations in the bioavailability of thiazinamium methylsulfate.
    Jonkman JH; Van Bork LE; Wijsbeek J; De Zeeuw RK; Orie NG
    Clin Pharmacol Ther; 1977 Apr; 21(4):457-63. PubMed ID: 849677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic first-pass effect of thiazinamium methylsulfate (N-methylpromethazine methylsulfate) in dogs.
    Jonkman JH; Westenberg HG; Van Der Kleyn E
    J Pharm Sci; 1981 Aug; 70(8):947-9. PubMed ID: 6118426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism and excretion of the quaternary ammonium compound thiazinamium methylsulfate (Multergan) in man. I. Parenteral administration.
    Jonkman JH; Wijsbeek J; De Zeeuw RA; Van Bork LE; Orie NG; Soeterboek AM; Bender J
    Pharm Weekbl Sci; 1982 Oct; 4(5):122-8. PubMed ID: 6128713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole body distribution of the quaternary ammonium compound thiazinamium (N-methylpromethazine) and promethazine in monkey and mice.
    Jonkman JH; Westenberg HG; Rijntjes NV; van der Kleijn E; Lindeboom SF
    Arzneimittelforschung; 1983; 33(2):223-8. PubMed ID: 6133524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacokinetics of intramuscular thiazinamium methyl sulfate.
    Jonkman JH; Van Bork LE; Calvert B; Greving JE; Wijsbeek J; De Zeeuw RA; Orie NG
    Int J Clin Pharmacol Ther Toxicol; 1983 Sep; 21(9):454-9. PubMed ID: 6138313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioavailability after intramuscular injection.
    Jonkman JH; van Bork LE; de Zeeuw RA; Orie NG
    Lancet; 1976 Mar; 1(7961):693. PubMed ID: 73664
    [No Abstract]   [Full Text] [Related]  

  • 12. Human whole blood and parotid saliva concentrations of oral and intramuscular promethazine.
    DiGregorio GJ; Ruch E
    J Pharm Sci; 1980 Dec; 69(12):1457-9. PubMed ID: 7463341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of low cencentrations of the quaternary ammonium compound thiazinamium methylsulphate in plasma and urine.
    Jonkman JG; Wijsbeek J; Hollenbeek S; de Boer SH; de Zeeuw RA; Van Bork LE; Orie NG
    J Pharm Pharmacol; 1975 Nov; 27(11):849-54. PubMed ID: 1494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 3rd Communication: suppositories.
    Lintz W; Barth H; Osterloh G; Schmidt-Böthelt E
    Arzneimittelforschung; 1998 Sep; 48(9):889-99. PubMed ID: 9793614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dye salt formation as a general method for colorimetric determination of antihistaminics. Part 2: Spectrophotometric determination of thenalidine maleate and thiazinamium methylsulphate in pure and dosage forms.
    Dessouky YM; Mousa BA; Nour el-Din HM
    Pharmazie; 1974 Sep; 29(9):579-80. PubMed ID: 4154007
    [No Abstract]   [Full Text] [Related]  

  • 16. Extrapyramidal reaction secondary to oral promethazine.
    Schwinghammer TL; Kroboth FJ; Juhl RP
    Clin Pharm; 1984; 3(1):83-5. PubMed ID: 6697679
    [No Abstract]   [Full Text] [Related]  

  • 17. [Biological availability of Tolectin after oral and rectal administration].
    Colombo B; Carrabba M; Sarchi C
    Boll Chim Farm; 1979 Mar; 118(3):176-82. PubMed ID: 475909
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacokinetic evaluation of ethionamide suppositories.
    Peloquin CA; James GT; McCarthy E; Goble M
    Pharmacotherapy; 1991; 11(5):359-63. PubMed ID: 1745621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative pharmacokinetic evaluation of compressed suppositories of diclofenac sodium in humans.
    Ramakrishna S; Fadnavis NW; Diwan PV
    Arzneimittelforschung; 1996 Feb; 46(2):175-7. PubMed ID: 8720309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of "irreversible" airway obstruction by thiazinamium (Multergan).
    Bouhuys A; Ortega J
    Pneumonologie; 1976 Jun; 153(3):185-95. PubMed ID: 785411
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.